IM Cannabis Reports Third Quarter 2022 Financial Results; Revenues Increased 78% YoY and 12% Sequentially

/PRNewswire/ -- IM Cannabis Corp. (the "Company", "IM Cannabis", or "IMC") (CSE: IMCC) (NASDAQ: IMCC), a leading medical cannabis company, provided financial...

Related Keywords

Germany ,United States ,Canada ,Roma ,Lazio ,Italy ,Toronto ,Ontario ,Israel ,Israeli ,Canadian ,German ,Haleli Barath ,Adjupharm Gmb ,Einat Zakariya ,Oren Shuster ,Vivian Bercovici ,Maya Lustig ,Herbs Ltd ,Company Israeli ,Company Contact ,Source Im Cannabis Corp ,High Way Shinua Ltd ,Nasdaq ,Canadian Securities Exchange ,Nutraceuticals Inc ,Prnewswire Im Cannabis Corp ,International Financial Reporting Standards ,Im Cannabis Corp ,Acquisition Corp ,Company Canadian ,Company Total Assets ,Nasdaq Stock Market ,Canadian Companie Creditors Arrangement Act ,Total Assets ,Chief Executive Officer ,Moti Marcus ,Avant Brands ,Favorite Strain ,Top Shelf Collection ,Watermelon Zkittlez ,Dried Flower ,Fair Value Adjustments ,Administrative Expenses ,Marketing Expenses ,Operating Expenses ,Continuing Operations ,Discontinued Operations ,Diluted Loss ,Cash Equivalents ,Common Share ,Common Shares ,Nasdaq Capital Market ,Direct Registration System ,Consolidation Common Shares ,Consolidation Common ,Focus Medical Herbs ,Adjupharm Gmbh ,Trichome Financial ,Nova Scotia ,Highland Grow ,Director Investor ,Focus Medical ,High Way Shinua ,Eastern Europe ,Cannabis ,Supplementary Medicine ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Banking Amp Financial Services ,Earnings ,